First-in-human Single and Multiple Dose Trial of ATR-258
Clinical trial NCT05409924 · COMPLETED
Trial details
- NCT number
- NCT05409924
- Sponsor
- Atrogi AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-11
- Primary completion
- 2023-10-04
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.